Healthcare provider profile · identity verified

Heidi Marie Coplin, MD

Internal Medicine · MINNEAPOLIS, MN · NPI 1851345672

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	345	88
Atorvastatin Calcium	Atorvastatin Calcium	302	87
Levothyroxine Sodium	Levothyroxine Sodium	264	66
Rosuvastatin Calcium	Rosuvastatin Calcium	237	74
Lisinopril	Lisinopril	185	51
Omeprazole	Omeprazole	182	52
Metoprolol Succinate	Metoprolol Succinate	175	56
Losartan Potassium	Losartan Potassium	139	42
Simvastatin	Simvastatin	131	36
Zolpidem Tartrate	Zolpidem Tartrate	129	33
Valsartan	Valsartan	127	32
Trazodone Hcl	Trazodone Hcl	126	37
Gabapentin	Gabapentin	125	30
Tramadol Hcl	Tramadol Hcl	118	21
Escitalopram Oxalate	Escitalopram Oxalate	99	31
Bupropion Xl	Bupropion Hcl	98	33
Venlafaxine Hcl Er	Venlafaxine Hcl	96	11
Pantoprazole Sodium	Pantoprazole Sodium	95	27
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	94	26
Furosemide	Furosemide	86	27
Eliquis	Apixaban	85	18
Metformin Hcl	Metformin Hcl	82	23
Albuterol Sulfate Hfa	Albuterol Sulfate	76	36
Sertraline Hcl	Sertraline Hcl	75	19
Hydrochlorothiazide	Hydrochlorothiazide	68	20
Carvedilol	Carvedilol	63	11
Oxycodone Hcl	Oxycodone Hcl	61	11
Estradiol	Estradiol	60	19
Alendronate Sodium	Alendronate Sodium	57	14
Fluticasone Propionate	Fluticasone Propionate	55	15
Tamsulosin Hcl	Tamsulosin Hcl	55	15
Lorazepam	Lorazepam	54	14
Ventolin Hfa	Albuterol Sulfate	53	13
Alprazolam	Alprazolam	52	suppressed
Valacyclovir	Valacyclovir Hcl	52	21
Clonazepam	Clonazepam	51	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	51	18
Allopurinol	Allopurinol	50	15
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	49	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	49	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	48	13
Tizanidine Hcl	Tizanidine Hcl	48	11
Duloxetine Hcl	Duloxetine Hcl	47	14
Pregabalin	Pregabalin	47	13
Amitriptyline Hcl	Amitriptyline Hcl	45	16
Fluoxetine Hcl	Fluoxetine Hcl	44	11
Metoprolol Tartrate	Metoprolol Tartrate	44	15
Finasteride	Finasteride	41	suppressed
Baclofen	Baclofen	39	suppressed
Ondansetron Odt	Ondansetron	37	18
Spironolactone	Spironolactone	37	11
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	36	suppressed
Lactulose	Lactulose	36	suppressed
Citalopram Hbr	Citalopram Hydrobromide	35	suppressed
Propranolol Hcl	Propranolol Hcl	35	suppressed
Potassium Chloride	Potassium Chloride	34	suppressed
Prednisone	Prednisone	34	23
Hydroxyzine Hcl	Hydroxyzine Hcl	32	13
Ketoconazole	Ketoconazole	32	14
Zaleplon	Zaleplon	32	suppressed
Montelukast Sodium	Montelukast Sodium	31	suppressed
Fluconazole	Fluconazole	30	12
Triamcinolone Acetonide	Triamcinolone Acetonide	30	16
Famotidine	Famotidine	29	11
Warfarin Sodium	Warfarin Sodium	29	suppressed
Xarelto	Rivaroxaban	28	suppressed
Metformin Hcl Er	Metformin Hcl	27	suppressed
Diazepam	Diazepam	24	suppressed
Latanoprost	Latanoprost	24	suppressed
Synthroid	Levothyroxine Sodium	24	suppressed
Meclizine Hcl	Meclizine Hcl	23	suppressed
Meloxicam	Meloxicam	23	suppressed
Bupropion Hcl Sr	Bupropion Hcl	22	suppressed
Cefadroxil	Cefadroxil	22	20
Nortriptyline Hcl	Nortriptyline Hcl	22	suppressed
Dulera	Mometasone/Formoterol	20	suppressed
Eszopiclone	Eszopiclone	20	suppressed
Jardiance	Empagliflozin	19	suppressed
Ozempic	Semaglutide	19	suppressed
Glimepiride	Glimepiride	18	suppressed
Lidocaine	Lidocaine	18	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	18	suppressed
Mounjaro	Tirzepatide	18	suppressed
Ropinirole Hcl	Ropinirole Hcl	18	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	18	suppressed
Azelastine Hcl	Azelastine Hcl	17	suppressed
Topiramate	Topiramate	17	suppressed
Amoxicillin	Amoxicillin	16	suppressed
Atenolol	Atenolol	16	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	16	12
Hydrocortisone	Hydrocortisone	16	suppressed
Loperamide	Loperamide Hcl	16	suppressed
Prazosin Hcl	Prazosin Hcl	16	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	15	15
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	15	suppressed
Carisoprodol	Carisoprodol	14	suppressed
Celecoxib	Celecoxib	14	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	14	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	14	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	14	suppressed
Lyrica	Pregabalin	14	suppressed
Nitroglycerin	Nitroglycerin	14	suppressed
Pravastatin Sodium	Pravastatin Sodium	14	suppressed
Acyclovir	Acyclovir	13	suppressed
Bupropion Hcl	Bupropion Hcl	13	suppressed
Ibuprofen	Ibuprofen	13	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	13	suppressed
Tretinoin	Tretinoin	13	suppressed
Anastrozole	Anastrozole	12	suppressed
Clopidogrel	Clopidogrel Bisulfate	12	suppressed
Fesoterodine Fumarate Er	Fesoterodine Fumarate	12	suppressed
Lovastatin	Lovastatin	12	suppressed
Mometasone Furoate	Mometasone Furoate	12	suppressed
Myrbetriq	Mirabegron	12	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	12	suppressed
Timolol Maleate	Timolol Maleate	12	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	11	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	11	suppressed
Methadone Hcl	Methadone Hcl	11	suppressed
Methylprednisolone	Methylprednisolone	11	suppressed
Nystop	Nystatin	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed
Propranolol Hcl Er	Propranolol Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error